Segment Information (Tables)

9 Months Ended

Jan. 31, 2016

Schedule of Segment Reporting Information, by Segment [Table Text Block]

The following tables summarize, for the periods indicated, operating results by reportable segment (table in thousands):

	Personalized		Translational
	Oncology		Oncology		Unallocated
	Solutions		Solutions		Corporate
Three Months Ended January 31, 2016	(POS)		(TOS)		Overhead		Consolidated
Net revenue	$	416	$	2,136	$	-	$	2,552
Direct cost of services		(479)		(1,624)		-		(2,103)
Sales and marketing costs		(183)		(569)		-		(752)
Other operating expenses		-		(950)		(553)		(1,503)
Stock- based compensation expense (1)		-		-		(567)		(567)

Segment profit (loss)	$	(246)	$	(1,007)	$	(1,120)	$	(2,373)

	Personalized		Translational
	Oncology		Oncology		Unallocated
	Solutions		Solutions		Corporate
Three Months Ended January 31, 2015	(POS)		(TOS)		Overhead		Consolidated
Net revenue	$	453	$	1,376	$	-	$	1,829
Direct cost of services		(672)		(1,300)		-		(1,972)
Sales and marketing costs		(366)		(613)		-		(979)
Other operating expenses		-		(1,028)		(612)		(1,640)
Stock- based compensation expense (1)		-		-		(657)		(657)

Segment profit (loss)	$	(585)	$	(1,565)	$	(1,269)	$	(3,419)

	Personalized		Translational
	Oncology		Oncology		Unallocated
	Solutions		Solutions		Corporate
Nine Months Ended January 31, 2016	(POS)		(TOS)		Overhead		Consolidated
Net revenue	$	1,387	$	6,958	$	-	$	8,345
Direct cost of services		(1,634)		(4,654)		-		(6,288)
Sales and marketing costs		(716)		(1,800)		-		(2,516)
Other operating expenses		-		(2,755)		(2,463)		(5,218)
Stock- based compensation expense (1)		-		-		(2,090)		(2,090)

Segment profit (loss)	$	(963)	$	(2,251)	$	(4,553)	$	(7,767)

	Personalized		Translational
	Oncology		Oncology		Unallocated
	Solutions		Solutions		Corporate
Nine Months Ended January 31, 2015	(POS)		(TOS)		Overhead		Consolidated
Net revenue	$	1,245	$	4,377	$	-	$	5,622
Direct cost of services		(2,171)		(3,205)		-		(5,376)
Sales and marketing costs		(1,243)		(1,650)		-		(2,893)
Other operating expenses		-		(3,490)		(2,413)		(5,903)
Stock- based compensation expense (1)		-		-		(2,284)		(2,284)

Segment profit (loss)	$	(2,169)	$	(3,968)	$	(4,697)	$	(10,834)

(1) Stock compensation expense is shown separately and is excluded from direct costs of services, sales and marketing costs, and other operating expenses, as it is managed on a consolidated basis and is not used by management to evaluate the performance of its segments.